Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Akemi Tokutsu
Observed name:
Tokutsu, Akemi
Institutions:
University of Occupational and Environmental Health Japan,
Aidu Chuo Hospital
Observed institutions:
University of Occupational and Environmental Health Japan,
Aidu Chuo Hospital
ORCID:
0000-0002-8035-5551
Observed ORCID:
0000-0002-8035-5551
OpenAlex ID:
A5058481316
Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial
2022
·
Atsushi Tanaka
, Masataka Sata
, et al.
·
European Heart Journal - Cardiovascular Pharmacotherapy
·
34
PDF
Relationship between blood glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics: Subanalysis of a prospective cohort study
2021
·
Akemi Tokutsu
, Yosuke Okada
, et al.
·
Diabetes Obesity and Metabolism
·
12
Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
2022
·
Kenichi Tanaka
, Yosuke Okada
, et al.
·
Scientific Reports
·
11
PDF
Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study
2020
·
Akemi Tokutsu
, Yosuke Okada
, et al.
·
Diabetology & Metabolic Syndrome
·
9
PDF
Long-term effects of ipragliflozin on blood pressure in patients with type 2 diabetes: insights from the randomized PROTECT trial
2023
·
Yuichi Saito
, Atsushi Tanaka
, et al.
·
Hypertension Research
·
8
PDF
Relationship between glycemic intraday variations evaluated in continuous glucose monitoring and HbA1c variability in type 2 diabetes: pilot study
2021
·
Akemi Tokutsu
, Yosuke Okada
, et al.
·
Diabetology & Metabolic Syndrome
·
8
PDF
Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study
2023
·
Shinji Kishimoto
, Yukihito Higashi
, et al.
·
Cardiovascular Diabetology
·
6
PDF
Addition of canagliflozin to insulin improves glycaemic control and reduces insulin dose in patients with type 2 diabetes mellitus: A randomized controlled trial
2019
·
Keiichi Torimoto
, Yosuke Okada
, et al.
·
Diabetes Obesity and Metabolism
·
5
Comparative effects of fixed‐dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial
2023
·
Kenichi Tanaka
, Yosuke Okada
, et al.
·
Journal of Diabetes Investigation
·
2
PDF
Possible involvement of CXCR3-CXCR6 + CD4 + T cells in Langerhans cell histiocytosis
2023
·
Akemi Tokutsu
, Yosuke Okada
, et al.
·
Journal of Bone and Mineral Metabolism
·
2
Response of thyrotropin-secreting pituitary tumors to preoperative lanreotide therapy. Report of two cases.
2020
·
Akemi Tokutsu
, Yosuke Okada
, et al.
·
Neuro-endocrinology letters
·
1
Author response for "Relationship between blood glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; sub‐analysis of prospective cohort study"
2021
·
Akemi Tokutsu
, Yosuke Okada
, et al.
·
Publons reviews and discussion
Author response for "Addition of canagliflozin to insulin improves glycemic control and reduces insulin dose in patients with type 2 diabetes mellitus: a randomized controlled trial"
2019
·
Keiichi Torimoto
, Yosuke Okada
, et al.
·
Publons reviews and discussion
Author response for "Addition of canagliflozin to insulin improves glycemic control and reduces insulin dose in patients with type 2 diabetes mellitus: a randomized controlled trial"
2019
·
Keiichi Torimoto
, Yosuke Okada
, et al.
·
Publons reviews and discussion
Show more works
View as search
Works count:
20
Citation count:
98
H-index:
6
I10-index:
3
Year
Topic
Type